retatrutide mechanism glp-1 gip glucagon triple agonist of action GLP-1-based therapies for type The Road towards Triple Agonists:
Description
Dig Liver Dis (2010) 42(5):32030
The funders had no role in the study design, data collection, analysis, interpretation of the evidence, decision to publish, or preparation of the manuscript
Overview of current and emerging GLP-1 receptor agonists
doi: 10.1016/j.cmet.2005.11.015
in rats, the half-life of exendin-4 is 1841 min, 125174 min, and 90216 min, respectively [194]
